These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, Part 2. Simone CB, Simone NL, Simone V, Simone CB. Altern Ther Health Med; 2007; 13(2):40-7. PubMed ID: 17405678 [Abstract] [Full Text] [Related]
6. Use of antioxidant supplements during breast cancer treatment: a comprehensive review. Greenlee H, Hershman DL, Jacobson JS. Breast Cancer Res Treat; 2009 Jun; 115(3):437-52. PubMed ID: 18839308 [Abstract] [Full Text] [Related]
7. Antioxidant supplements during cancer treatments: where do we stand? Hamilton KK. Clin J Oncol Nurs; 2001 Jun; 5(4):181-2. PubMed ID: 12690623 [Abstract] [Full Text] [Related]
8. Phase I and pharmacokinetic study of pemetrexed plus cisplatin in chemonaive patients with locally advanced or metastatic malignant pleural mesothelioma or non-small cell lung cancer. Dickgreber NJ, Fink TH, Latz JE, Hossain AM, Musib LC, Thomas M. Clin Cancer Res; 2009 Jan 01; 15(1):382-9. PubMed ID: 19118069 [Abstract] [Full Text] [Related]
9. Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice. Lee CK, Son SH, Park KK, Park JH, Lim SS, Kim SH, Chung WY. Basic Clin Pharmacol Toxicol; 2008 Jul 01; 103(1):48-54. PubMed ID: 18484961 [Abstract] [Full Text] [Related]
10. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. Pace A, Savarese A, Picardo M, Maresca V, Pacetti U, Del Monte G, Biroccio A, Leonetti C, Jandolo B, Cognetti F, Bove L. J Clin Oncol; 2003 Mar 01; 21(5):927-31. PubMed ID: 12610195 [Abstract] [Full Text] [Related]
11. Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature. Vilmar A, Sørensen JB. Lung Cancer; 2009 May 01; 64(2):131-9. PubMed ID: 18804893 [Abstract] [Full Text] [Related]
12. Antioxidants in cancer care: when and how to use them as an adjunct to standard and experimental therapies. Prasad KN. Expert Rev Anticancer Ther; 2003 Dec 01; 3(6):903-15. PubMed ID: 14686711 [Abstract] [Full Text] [Related]
13. Hyperthermia, cisplatin and radiation trimodality treatment: a promising cancer treatment? A review from preclinical studies to clinical application. Bergs JW, Franken NA, Haveman J, Geijsen ED, Crezee J, van Bree C. Int J Hyperthermia; 2007 Jun 01; 23(4):329-41. PubMed ID: 17558732 [Abstract] [Full Text] [Related]
14. Current status and future prospects for satraplatin, an oral platinum analogue. Choy H, Park C, Yao M. Clin Cancer Res; 2008 Mar 15; 14(6):1633-8. PubMed ID: 18347164 [Abstract] [Full Text] [Related]
15. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. J Natl Cancer Inst; 2008 Jun 04; 100(11):773-83. PubMed ID: 18505970 [Abstract] [Full Text] [Related]
16. Use of single cell gel electrophoresis assays for the detection of DNA-protective effects of dietary factors in humans: recent results and trends. Hoelzl C, Knasmüller S, Misík M, Collins A, Dusinská M, Nersesyan A. Mutat Res; 2009 Jun 04; 681(1):68-79. PubMed ID: 18755290 [Abstract] [Full Text] [Related]
17. Chemoprevention of colorectal cancer: why all the confusion? Bresalier RS. Curr Opin Gastroenterol; 2008 Jan 04; 24(1):48-50. PubMed ID: 18043232 [Abstract] [Full Text] [Related]
18. Do diet, folic acid, and vitamins matter? What did we learn from the Women's Health Initiative, the Women's Health Study, the Women's Antioxidant and Folic Acid Cardiovascular Study, and other clinical trials? Wenger NK. Cardiol Rev; 2007 Jan 04; 15(6):288-90. PubMed ID: 18090063 [Abstract] [Full Text] [Related]
19. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Low PS, Henne WA, Doorneweerd DD. Acc Chem Res; 2008 Jan 04; 41(1):120-9. PubMed ID: 17655275 [Abstract] [Full Text] [Related]
20. Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends. Moreno-Aspitia A, Perez EA. Clin Ther; 2009 Aug 04; 31(8):1619-40. PubMed ID: 19808124 [Abstract] [Full Text] [Related] Page: [Next] [New Search]